LARRY N FEINBERG
CIK 926475 · last filed 2021-02-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$34.72M
Companies
7
Total Filings
62
Lifetime Open-Market Net
$125.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MOTS | 10%+ Owner | 0 | $0.00 | $0 | $5.97M | 2 | 2021-02-05 |
| SLNO | 10%+ Owner | 655,000 | $53.01 | $34.72M | -$1.36M | 2 | 2020-09-30 |
| Aspira Women's Health Inc. (VRML) Delisted | 10%+ Owner | 2,595,980 | — | — | $8.40M | 3 | 2020-06-10 |
| BIOLASE, INC (BIOL) Delisted | 10%+ Owner | 12,765 | $0.02 | $222 | $39.31M | 12 | 2019-10-31 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | 10%+ Owner | 2,615,481 | — | — | $2.50M | 3 | 2019-03-18 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | 10%+ Owner | 654,090 | $0.03 | $22.2K | $1.27M | 21 | 2016-02-09 |
| HANSEN MEDICAL INC (HNSN) Delisted | 10%+ Owner | 31,132,909 | — | — | $69.18M | 18 | 2015-05-14 |
Recent Filings · Page 2 of 7
62 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-08-30 | Aspira Women's Health Inc. (VRML) Delisted | Mixed | — | $0 | EDGAR |
| 2016-11-10 | BIOLASE, INC (BIOL) Delisted | Conv (C) | +381,000 | $646.6K | EDGAR |
| 2016-10-05 | BIOLASE, INC (BIOL) Delisted | Mixed | +11,097,300 | $12.54M | EDGAR |
| 2016-08-10 | BIOLASE, INC (BIOL) Delisted | Buy (P) | — | $0 | EDGAR |
| 2016-07-29 | — | Disp (D) | −22,418,070 | -$210527.47B | |
| 2016-02-09 | Accelerate Diagnostics, Inc (AXDX) Delisted | Sell (S) | −600,000 | -$7.12M | EDGAR |
| 2015-12-29 | Accelerate Diagnostics, Inc (AXDX) Delisted | Exer (X) | +100,000 | $1.75M | EDGAR |
| 2015-12-22 | Accelerate Diagnostics, Inc (AXDX) Delisted | Exer (X) | +100,000 | $1.75M | EDGAR |
| 2015-12-10 | Accelerate Diagnostics, Inc (AXDX) Delisted | Buy (P) | +117,647 | $2.00M | EDGAR |
| 2015-11-12 | BIOLASE, INC (BIOL) Delisted | Buy (P) | +54,800 | $43.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.